speb/financial-data huggingface dataset:
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -239000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 13517000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 13517000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -51317000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 10674000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -43000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Payable: 74878000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -137265000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -105052000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -21403000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Common Stock: 264697000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 264697000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 2733260000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2733260000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 2590000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 32523000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 32523000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 772041000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 165512000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1158153000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1158153000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 13427000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 13427000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Debt: 81855000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 81855000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 95282000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 95282000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 346406000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 346406000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 4090000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 4090000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Depreciation: 142855000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 142855000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 142854000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 35830000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 142854000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 35830000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 26521006.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 26426000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Diluted EPS: 14.71
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.50
ORBTEXP.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 66065000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1193000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1193000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 19000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — EBIT: 541189000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — EBIT: 92582000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — EBITDA: 684044000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — EBITDA: 128412000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 80000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — End Cash Position: 13517000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 390872000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 390872000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -99512000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 327258000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 327258000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 282868000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -14171000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -76083000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 33704000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 3710000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3710000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 326873000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 326873000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2225618000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2225618000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Gross Profit: 1364990000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 331283000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 120777000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 120777000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Interest Expense: 18514000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 4077000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 18514000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 4077000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Interest Income: 17294000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 17294000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -13882000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 17058000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Inventory: 522771000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 522771000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 2842556000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2842556000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -256747000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 511649000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 511649000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 212204000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 212204000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 2590000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 169102000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 169102000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 28377000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 28377000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 27441000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 27441000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 55818000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 55818000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -68327000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 212204000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 212204000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 27723000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 27723000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1551631000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1551631000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 2590000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Net Debt: 95779000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 95779000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 1725000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income: 66065000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 66065000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 66065000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 66065000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 66065000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 522675000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 66065000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Interest Income: -18514000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -4077000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -297853000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -65751000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -68327000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -18514000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4077000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1372421000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1372421000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 33460000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 2576000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 2729550000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2729550000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 25531000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 25531000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 117896000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 117896000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 27723000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 27723000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 23497000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 23497000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 684044000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 128412000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Normalized Income: 390124000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 66065000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 334856000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Operating Income: 398527000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Operating Income: 79028000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Operating Revenue: 2137031000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 496795000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 26469652.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 26469652.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 4008000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 11412000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 11412000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 9335000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 9335000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4722000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4722000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 3710000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 3710000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -11246000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 6799000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6799000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 25531000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 25531000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 129318000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 8966000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 543091000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 139212000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Payable: 559000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 559000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Properties: 37071000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 37071000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 20103000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 20103000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 100692000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 100692000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Other Special Charges: -76083000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Payables: 126494000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Payables: 126494000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 6228000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 24945000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 24945000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 32590000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 32590000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Pretax Income: 522675000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 88505000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 2481000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -695449000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -51988000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 101089000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 101089000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 772041000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 165512000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 142855000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 35830000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 16032000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 16032000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -68327000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 67053000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 67053000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2416700000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2416700000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 397596000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 85448000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 27965000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 61669000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Share Issued: 26469652.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 26469652.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 760000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 2733260000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2733260000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2729550000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2729550000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Tax Provision: 132551000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 22440000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 66003000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 66003000.00
ORBTEXP.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -127137000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Assets: 3306634000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 3306634000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 2760701000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2760701000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Debt: 151100000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 151100000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2733260000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2733260000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Total Expenses: 1738504000.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 417767000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 573374000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 573374000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2148481000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2148481000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 226968000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 226968000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 1721000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1721000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Work In Process: 94424000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 94424000.00
ORBTEXP.NS balance_sheet (annual, 2025-03-31) — Working Capital: 811747000.00
ORBTEXP.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 811747000.00
ORBTEXP.NS income_statement (annual, 2025-03-31) — Write Off: 5165000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 249853000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 658765000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 26470018.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 5.67
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 254295000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 34764000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 34764000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26516784.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 5.66
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — EBIT: 197154000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — EBITDA: 231918000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 404470000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 4496000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4496000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 150055000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -4496000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4496000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 231918000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 150085000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Operating Income: 154617000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 658765000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 38286000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 141436000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 192658000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 254295000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 34764000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 42603000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 504148000.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ORBTEXP.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4484000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 269388000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 552617000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26546559.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.47
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 203020000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 37641000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 37641000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26546559.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.47
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — EBIT: 95199000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — EBITDA: 132840000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 349597000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 2608000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2608000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2608000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2608000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 132840000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 65570000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Operating Income: 80209000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 552617000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 11251000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 138236000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 92591000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 203020000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 37641000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 27021000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 472408000.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1055809000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 279178000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 2266675000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 483420000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 141493000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 141493000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 268499000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 268499000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1204282000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1204282000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 26493176.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26894595.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Basic EPS: 12.31
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.37
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 13518000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -133054000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 115923000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 115923000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 265112000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 265112000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 30331000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 30331000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 102619000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 102619000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -66000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -26074000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 2993000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 74929000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Payable: -3927000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 55501000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 102199000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 16384000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Common Stock: 265112000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 265112000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 3074593000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3074593000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 2324000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 2221000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2221000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 856806000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 168522000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1048738000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1048738000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 19083000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 19083000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Debt: 22725000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 22725000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 41808000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 41808000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 367216000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 367216000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 4374000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 4374000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Depreciation: 146742000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 146742000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 146742000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 39116000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 146742000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 39116000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 26536290.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26894595.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Diluted EPS: 12.29
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.37
ORBTEXP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 9951000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 1117000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — EBIT: 447500000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — EBIT: 18454000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — EBITDA: 594242000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — EBITDA: 57570000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 429000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 30331000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -92523000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 440651000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 50035000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 1631000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 14707000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 14707000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1454308000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1454308000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Gross Profit: 1409869000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 314898000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Interest Expense: 14073000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 4253000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 14073000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4253000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -8903000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 30248000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Inventory: 562602000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 562602000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 3121947000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3121947000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -464798000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1204282000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1204282000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 2324000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 96840000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 96840000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 24629000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 24629000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 121469000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 121469000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -2812000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 39620000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 39620000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 2324000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Net Debt: 17023000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 17023000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -6638000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income: 9951000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 9951000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 9951000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 9951000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 9951000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 433427000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 9951000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Interest Income: -14073000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -4253000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -354427000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -61942000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -2812000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -14073000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4253000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1454308000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1454308000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -131786000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -59130000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 3059886000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3059886000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 103517000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 103517000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 594242000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 57570000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Normalized Income: 326131000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 9951000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 573705000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Operating Income: 354060000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Operating Income: 35720000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 2266675000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 483420000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 26511152.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 26511152.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -1849000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 110295000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 110295000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 123355000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 123355000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 2809481000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2809481000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 14707000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 14707000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -47885000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 4871000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 4871000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 20491000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 20491000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 78973000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -18260000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 576741000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 153085000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1452087000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1452087000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4723000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4723000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 72288000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 72288000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Payables: 151708000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 151708000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 12464000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Pretax Income: 433427000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 14201000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 632000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1171821000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -133054000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 856806000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 168522000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 146742000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 39116000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -2812000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 817394000.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1268000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 26511152.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 26511152.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 528000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 3074593000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3074593000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 3059886000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3059886000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Tax Provision: 107296000.00
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 4250000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
ORBTEXP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.30
ORBTEXP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -113011000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 3726906000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 3726906000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 3099222000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3099222000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Total Debt: 163277000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 163277000.00
ORBTEXP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 3074593000.00
ORBTEXP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3074593000.00
ORBTEXP.NS income_statement (annual, 2026-03-31) — Total Expenses: 1912615000.00